Strategic Wealth Investment Group, LLC Age X Therapeutics, Inc. Transaction History

Strategic Wealth Investment Group, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$0.33 - $0.74 $1,574 - $3,531	4,772 Added 5.15%	97,375 $37,000
Q3 2023 Nov 03, 2023	BUY	$0.67 - $0.85 $7,048 - $8,942	10,520 Added 12.82%	92,603 $62,000
Q2 2023 Jul 17, 2023	SELL	$0.45 - $0.89 $1,774 - $3,509	-3,943 Reduced 4.58%	82,083 $73,000
Q1 2023 Apr 24, 2023	BUY	$0.56 - $0.8 $47,838 - $68,340	85,426 Added 14237.67%	86,026 $56,000
Q1 2023 Apr 20, 2023	SELL	$0.56 - $0.8 $48,070 - $68,672	-85,840 Reduced 99.31%	600 $0
Q4 2022 Jan 27, 2023	BUY	$0.54 - $0.68 $2,392 - $3,012	4,430 Added 5.4%	86,440 $0
Q3 2022 Oct 21, 2022	SELL	$0.55 - $0.74 $13,215 - $17,780	-24,028 Reduced 22.66%	82,010 $46,000
Q2 2022 Aug 08, 2022	SELL	$0.57 - $1.0 $5,229 - $9,175	-9,175 Reduced 7.96%	106,038 $61,000
Q1 2022 Apr 26, 2022	BUY	$0.65 - $1.2 $1,925 - $3,554	2,962 Added 2.64%	115,213 $98,000
Q4 2021 Jan 21, 2022	BUY	$0.53 - $1.09 $10,234 - $21,048	19,311 Added 20.78%	112,251 $122,000
Q3 2021 Nov 15, 2021	BUY	$0.93 - $1.54 $25,810 - $42,739	27,753 Added 42.57%	92,940 $87,000
Q2 2021 Jul 16, 2021	BUY	$1.14 - $1.77 $6,884 - $10,689	6,039 Added 10.21%	65,187 $101,000
Q1 2021 Apr 22, 2021	BUY	$1.56 - $2.7 $5,703 - $9,871	3,656 Added 6.59%	59,148 $96,000
Q4 2020 Jan 26, 2021	BUY	$0.8 - $2.56 $44,393 - $142,059	55,492 New	55,492 $84,000
Q4 2020 Jan 15, 2021	SELL	$0.8 - $2.56 $45,860 - $146,752	-57,325 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$0.79 - $1.52 $8,032 - $15,455	10,168 Added 21.56%	57,325 $46,000
Q2 2020 Jul 13, 2020	BUY	$0.68 - $1.13 $32,066 - $53,287	47,157 New	47,157 $45,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Strategic Wealth Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Investment Group, LLC with notifications on news.